# Ovid Therapeutics Inc.: Form 8-K, filed Jun 17, 2024

- Company: [Ovid Therapeutics Inc.](/companies/ovid.md) (CIK 1636651)
- Form: 8-K
- Filed: 2024-06-17
- Accepted by EDGAR: Jun 17, 2024, 07:10 ET
- Period: 2024-06-17
- Accession: 0000950170-24-073998
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636651/000095017024073998/ovid-20240617.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636651/000095017024073998/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636651/000095017024073998/ovid-20240617.htm

Filed Jun 17, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-073998. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.